Sumi Sukanya

ICMR scientist says existing tests to diagnose life-threatening bacterial disease 'not very reliable'. India reports nearly 45 lakh cases of typhoid each year, highest in the world.

Takeda's QDENGA, designed to protect against all 4 dengue virus serotypes, has been recommended by Strategic Advisory Group of Experts on Immunization for use in endemic countries.

CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.

Study by researchers affiliated to London School of Hygiene & Tropical Medicine, in collaboration with WHO & UNICEF, says a decade made little difference in percentage of preterm births in India.

National Medical Commission's rule of 100 MBBS seats/10L population has doctors divided & became talking point among Oppn leaders who expressed concern about impact on southern states.

Advisory by American Heart Association classifies cardiovascular-kidney-metabolic (CKM) syndrome into 4 stages, with therapeutic & screening strategies suggested for each.

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

Therapy developed by IIT-Bombay spin-off company ImmunoACT approved for relapsed-refractory B-cell lymphoma, leukemia, to be available in around 20 govt & pvt hospitals across major cities.

Through a 20 September circular, the Union Health Ministry allowed MBBS candidates, who had appeared for NEET-PG, 2023, to opt for leftover seats in medical colleges. But has not got a favourable response as these seats are in non-clinical branches.

At review meet, health minister says between 2015 & 2023, convictions under Pre-Conception and Pre-Natal Diagnostic Techniques (Regulation & Prevention of Misuse) Act went from 271 to 713.